Almirall Stock News
€10.08
0.20%
Madrid, Oct 09, 05:35 pm CEST.
Closed.
ISIN
ES0157097017
Symbol
ALM
Industry
Almirall Stock News
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026
VIENNA--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, today announced its scientific programme at the 35th European Academy of Dermatology and Venereology (EADV) Congress, taking place in Vienna from 30 September to 3 October 2026. As Gold Sponsor of this year's congress, Almirall will present more than 20 abstracts on clinical and r...
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has accepted the submission of the extension of the Marketing Authorisation Application (MAA) of Ebglyss® (lebrikizumab) for the treatment of children and adolescents aged 6 months to
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
